Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.

Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Abstract Text:

    thomas c lauensteinThomas C Lauenstein,khalil salmanKhalil Salman,roger morreiraRoger Morreira,thomas heffronThomas Heffron,james r spiveyJames R Spivey,enrique martinezEnrique Martinez,puneet sharmaPuneet Sharma,diego r martinDiego R Martin,

    OBJECTIVE: The purpose of this study was to evaluate prospectively acquired institutional results to determine the accuracy of gadolinium-enhanced MRI in liver tumor surveillance before transplantation. SUBJECTS AND METHODS: One hundred fifteen patients underwent MRI of the abdomen within 90 days before liver transplantation. Images were acquired with gadolinium-enhanced 3D gradient-echo sequences in the arterial, venous, and delayed phases. Detection of hepatocellular carcinoma (HCC) was based on the imaging criteria arterial phase enhancement, delayed phase hypointensity, and development of an enhancing outer margin capsule. Imaging findings were compared with findings at histopathologic evaluation of the explanted liver. RESULTS: Thirty-six HCCs in 27 patients were detected at histopathologic evaluation. Patient-based analysis showed the sensitivity of MRI was 88.9% (24/27); specificity, 97.7% (false-positive findings in two patients); and accuracy, 95.7%. MRI depicted 28 of 36 HCCs, resulting in a lesion-based sensitivity of 77.8%. Although all 18 HCCs 2 cm or larger were depicted with MRI, only 10 of 18 HCCs smaller than 2 cm were correctly diagnosed. However, two HCCs measuring smaller than 2 cm at pathologic examination were rated as dysplastic nodules on MRI. CONCLUSION: Contrast-enhanced MRI can be used as a primary diagnostic method for accurate detection and characterization of HCC 2 cm or larger as required by the criteria of the Model for End-Stage Liver Disease used by the United Network for Organ Sharing. MRI can be considered a standard tool for surveillance before liver transplantation. Reduction in cost and risk may be derived from the diminished need for other diagnostic imaging studies and biopsy and the avoidance of use of iodinated contrast agents in imaging of patients with cirrhosis, many of whom have impaired renal function.

    Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Publishing Authors By Initials

    tc lauensteinTC Lauenstein,k salmanK Salman,r morreiraR Morreira,t heffronT Heffron,jr spiveyJR Spivey,e martinezE Martinez,p sharmaP Sharma,dr martinDR Martin,

    For similar surgical procedures, operative: transplantation research abstracts see: surgical procedures, operative: transplantation research

    PUBMED ID PMID:

    MEDLINE DATE:

    Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: AJR. American journal of roentgenology

    VOLUME: 189

    Page Numbers: 663-70

    Journal Abbreviation:

    ISSN: 1546-3141

    DAY: 15

    MONTH: Sep

    YEAR: 2007

    Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708173

    Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Keywords Mesh Terms:

    KEYWORDS: Transplantation

    MESH TERMS: pathology

    Chemical & Substance for Abstract: Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. Information

    Substance Name: Gadolinium

    Registry Number: 7440-54-2

    Grant and Affiliation Information for Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.

    AFFILIATION: Department of Radiology, Emory University Hospital, Emory Clinic, Bldg. A, Ste. AT-627, 1365 Clifton Rd., Atlanta, GA 30322, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJR Am J Roentgenol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News